RubrYc Therapeutics is a biotechnology company.
RubrYc Therapeutics has raised $7.5M in total funding. The most recent round was Series A. The last funding was announced in August 2021.
RubrYc Therapeutics's investors include Third Point Ventures, Paladin Capital Group, iBio, Vital Venture Capital, Hayan Health Networks.
RubrYc Therapeutics is headquartered in San Ramon, United States.
RubrYc Therapeutics is a biotechnology company.
RubrYc Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RubrYc Therapeutics — Funding & Investors." VCBacked, August 25, 2021, https://www.vcbacked.co/company/rubryc-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). RubrYc Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rubryc-therapeutics
{{cite web |title=RubrYc Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rubryc-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated